RVXCF (Resverlogix) Net Intangibles Purchase And Sale : $-0.52 Mil (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Resverlogix Net Intangibles Purchase And Sale?

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Resverlogix's net Intangibles purchase and sale for the three months ended in Mar. 2025 was $-0.23 Mil. Its net Intangibles purchase and sale for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.52 Mil.

Resverlogix Net Intangibles Purchase And Sale Historical Data

The historical data trend for Resverlogix's Net Intangibles Purchase And Sale can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Net Intangibles Purchase And Sale Chart

Resverlogix Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

Dec24

Net Intangibles Purchase And Sale

Get a 7-Day Free Trial

-0.49

-0.88

-0.45

-0.47

Resverlogix Quarterly Data
	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Intangibles Purchase And Sale	Get a 7-Day Free Trial															-0.18	-0.05	-0.17	-0.08	-0.23

Resverlogix Net Intangibles Purchase And Sale Calculation

Net Intangibles Purchase And Sale for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

Resverlogix Net Intangibles Purchase And Sale Related Terms

Thank you for viewing the detailed overview of Resverlogix's Net Intangibles Purchase And Sale provided by GuruFocus.com. Please click on the following links to see related term pages.

Resverlogix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (OTCPK:RVXCF) » Definitions » Net Intangibles Purchase And Sale

Comparable Companies

Traded in Other Exchanges

RVX:Canada

Address

4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1

Website

https://www.resverlogix.com

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.